newsfilter
← Latest News
GlobeNewswire·

Akebia Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Discuss Recent Business Highlights

  • Akebia Therapeutics will release fourth quarter & full year 2025 financial results on February 26, 2026, prior to market open.
  • A conference call to discuss results & business highlights is scheduled for February 26, 2026, at 8:00 a.m. EST.
  • Registration is required via a provided link to obtain dial-in details for the call.
  • Participants are encouraged to dial in 15 minutes before the scheduled start time.
  • A live webcast & online archive will be available in the Investors section of Akebia's website.
  • Akebia Therapeutics is a biopharmaceutical company founded in 2007 & headquartered in Cambridge, Massachusetts.